Orchestra BioMed Holdings, Inc.
OBIO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $147,284 | $303,346 | $149,586 | $206,136 |
| - Cash | $22,261 | $30,559 | $19,784 | $9,938 |
| + Debt | $16,529 | $1,687 | $11,870 | $5,673 |
| Enterprise Value | $141,552 | $274,474 | $141,672 | $201,871 |
| Revenue | $2,638 | $2,760 | $3,533 | -$782 |
| % Growth | -4.4% | -21.9% | 551.8% | – |
| Gross Profit | $2,434 | $2,574 | $3,211 | -$981 |
| % Margin | 92.3% | 93.3% | 90.9% | 125.4% |
| EBITDA | -$63,993 | -$51,219 | -$32,435 | -$21,618 |
| % Margin | -2,425.8% | -1,855.8% | -918.1% | 2,764.5% |
| Net Income | -$61,024 | -$49,120 | -$33,608 | -$23,014 |
| % Margin | -2,313.3% | -1,779.7% | -951.3% | 2,943% |
| EPS Diluted | -1.66 | -1.48 | -1.32 | -0.019 |
| % Growth | -12.2% | -12.1% | -7,035.1% | – |
| Operating Cash Flow | -$50,558 | -$46,127 | -$29,289 | -$19,429 |
| Capital Expenditures | -$289 | -$78 | -$591 | -$274 |
| Free Cash Flow | -$50,847 | -$46,205 | -$29,880 | -$19,703 |